GE HealthCare Technologies
GEHCGE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions.
Earnings
Next report
Jul 29, 2026 (In 2 weeks)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions. The company focuses on delivering precision care through a combination of hardware, AI-enabled software, and clinical services to help clinicians diagnose and treat complex diseases. Its value proposition centers on integrating diagnostic tools with data-driven insights to improve patient outcomes and operational efficiency for healthcare providers.
A leading global provider with a 130-year history and a massive installed base of connected devices across 160 countries.
Questions, answered.
- What is GE HealthCare Technologies's market cap?
- GE HealthCare Technologies (GEHC) has a market capitalization of $29.4B and trades on NASDAQ.
- What is GE HealthCare Technologies's revenue and profitability?
- GE HealthCare Technologies generated $21.0B in trailing twelve-month revenue with net income of $1.9B, representing a net margin of 9.1%. Gross margin stands at 39.1%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.
- Who are GE HealthCare Technologies's competitors?
- GE HealthCare Technologies's key competitors include Philips Healthcare, RadNet, Inc. Common Stock, Lumexa Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does GE HealthCare Technologies partner with?
- GE HealthCare Technologies's notable partners include GE Aerospace.
- Where is GE HealthCare Technologies headquartered?
- GE HealthCare Technologies is headquartered in United States of America and employs approximately 51,000 people. It has been publicly traded since 2022.
